edatrexate has been researched along with Mucositis, Oral in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodurtha, A; Boos, G; Bramwell, V; Eisenhauer, E; Knowling, M; Quirt, I | 1 |
| Ramos-Remus, C; Russell, AS; Skeith, KJ | 1 |
| Perez, EA | 1 |
| Dreicer, R; Kirkwood, JM; Kuzel, T; Loehrer, PJ; O'Dwyer, PJ; Propert, KJ | 1 |
| Hong, WK; Lee, JS; Murphy, WK; Pang, A; Shirinian, MH | 1 |
2 trial(s) available for edatrexate and Mucositis, Oral
| Article | Year |
|---|---|
Phase II trial of 10-EDAM in advanced soft tissue sarcoma. A study of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Canada; Female; Folic Acid Antagonists; Humans; Male; Middle Aged; Mouth Mucosa; Neutropenia; Sarcoma; Soft Tissue Neoplasms; Stomatitis | 1994 |
A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Bone Marrow Diseases; Carcinoma, Renal Cell; Female; Gastrointestinal Diseases; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Remission Induction; Stomatitis; Survival Analysis | 1997 |
3 other study(ies) available for edatrexate and Mucositis, Oral
| Article | Year |
|---|---|
Comparative efficacy and toxicity of 10-ethyl-10-deazaaminopterin and methotrexate in a mycobacterial rat arthritis model.
Topics: Aminopterin; Animals; Arthritis, Experimental; Drug Evaluation, Preclinical; Female; Intestinal Diseases; Methotrexate; Nontuberculous Mycobacteria; Peritonitis; Rats; Rats, Inbred Lew; Stomatitis | 1994 |
Schedule-dependent edatrexate toxicity.
Topics: Aminopterin; Antineoplastic Agents; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Methotrexate; Mouth Mucosa; Palliative Care; Stomatitis | 1996 |
Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.
Topics: Aminopterin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; Female; Folic Acid Antagonists; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Stomatitis | 1991 |